• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Catalog Number CLXUSA
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/10/2023
Event Type  malfunction  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the reportable malfunction pressure dome leak.Since this reportable malfunction is only associated with the kit, this mdr will only be against the kit.A batch record review for kit lot l348 was conducted.There were no non-conformances associated with this lot.This lot met all release requirements.A review of kit lot l348 shows no trends.Trends were reviewed for complaint categories, pressure dome membrane leak and alarm #18: system pressure.No trends were detected for these complaint categories.This assessment is based on the information available at the time of the investigation.At the time of this report, the analysis of the returned kit is still in progress.A supplemental report will be filed when the analysis is complete.(b)(4).Hm: (b)(6) 2023.
 
Event Description
The customer contacted mallinckrodt to report they experienced a pressure dome leak with their cellex photopheresis kit ("kit") during an extracorporeal photopheresis (ecp) treatment.The customer reported they observed a leak at the system pressure dome after 400 ml of whole blood had been processed.The customer reported that an alarm #18: system pressure alarm occurred and then the blood leak was observed.The ecp treatment was aborted and no residual blood within the kit was retuned to the patient.The patient was reported to be in stable condition.The customer returned the kit for investigation.
 
Manufacturer Narrative
The kit was returned for evaluation.The smart card was not returned for evaluation, therefore the reported alarm #18: system pressure could not be confirmed.The kit was returned intact and dried blood was observed on the body and membrane of the system pressure dome, confirming the reported complaint.Examination of the returned kit found the diaphragm was partially unseated from the body of the system pressure dome.The pressure dome was inspected and no obvious manufacturing issues were found.The diaphragm was put back into place on the body of the pressure dome and was pressure tested to check for leaks.Pressure testing of the pressure dome did not result in any leaks.If a pressure dome is not properly attached to its pressure sensor because one of its latches isn't secured in the circumferential groove around the sensor, the diaphragm of the pressure dome will have room to move and can become unseated when pressure is increased.All cellex kits are leak tested prior to packaging.A leak of this nature would have been detected during in-process testing; therefore, it is unlikely the pressure dome leaked at the time of manufacture.The cause of the reported leak was most likely due to the diaphragm becoming unseated from the body of the pressure dome.The root cause of the pressure dome leak was most likely due to the pressure dome not being secured to the pressure sensor during installation of the pressure dome by the end user.No further action is required at this time.This investigation is now complete.(b)(4).H.M.25 apr 2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
blanchardstown, dublin, D15 T X2V
EI  D15 TX2V
Manufacturer (Section G)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
college business & tech park
cruiserath road
blanchardstown, dublin, D15 T X2V
EI   D15 TX2V
Manufacturer Contact
mark wendelken
440 route 22 east
suite 302
bridgewater, NJ 08807
MDR Report Key16477500
MDR Text Key310957381
Report Number3013428851-2023-00010
Device Sequence Number1
Product Code LNR
UDI-Device Identifier20705030200003
UDI-Public(01)20705030200003(10)L348(17)240801
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 04/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberCLXUSA
Device Lot NumberL348
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/24/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/10/2023
Initial Date FDA Received03/03/2023
Supplement Dates Manufacturer Received04/13/2023
Supplement Dates FDA Received04/25/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/26/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age13 YR
Patient SexMale
-
-